Ms Emma Carys Price
BRITISHUNITED KINGDOMBorn August 1993
Current Appointments20
Schuylkill Limited
—director · Since 11/12/2025
Shenandoah Limited
—director · Since 11/12/2025
Hdi Lionel Holding, Llc
—director · Since 05/12/2023
Hdi Lionel West Holdings Ltd.
—director · Since 05/12/2023
Hdi Lionel East Holdings Ltd.
—director · Since 05/12/2023
Myovant Holdings Limited
—director · Since 06/10/2023
Affivant Sciences Holdings Limited
—director · Since 06/10/2023
Enzyvant Therapeutics Holdings Limited
—director · Since 06/10/2023
Urovant Holdings Limited
—director · Since 06/10/2023
Izana Bioscience Limited
—director · Since 06/10/2023
Altavant Sciences Holdings Limited
—director · Since 06/10/2023
Ophthovant Holdings Limited
—director · Since 06/10/2023
Metavant Holdings Limited
—director · Since 06/10/2023
Emavant Solutions Holdings Limited
—director · Since 06/10/2023
Respivant Sciences Holdings Ltd.
—director · Since 06/10/2023
Lysovant Sciences Holdings Limited
—director · Since 06/10/2023
Pharmavant 3 Holdings Ltd.
—director · Since 06/10/2023
Aimia Holdings Uk Ii Limited
—director · Since 26/04/2023
Barcomarine Limited
—director · Since 05/08/2022
D&B Finance Limited
—director · Since 18/02/2022
Summary
Current roles20
Former roles0
NationalityBRITISH
Based inUNITED KINGDOM
DOBBorn August 1993
Risk flags None detected
Financial FootprintActive cos.
Combined net worth£24k
Combined profit£-25k
Total employees0
Based on latest filed accounts for 4 of 20 active companies.
Frequently Works With
Data sourced from Companies House public register. Financial data from filed accounts. Updated as filings are processed.